A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
Type 2 Diabetes

About this trial
This is an interventional treatment trial for Type 2 Diabetes focused on measuring Diabetes Mellitus, Type 2, Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, Metabolic Diseases, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Hypoglycemic Agents, Pharmacologic Actions, Physiological Effects of Drugs
Eligibility Criteria
Key inclusion criteria
- Participants willing and able to give signed and written informed consent
- Males and females, aged 18 to 89 years, who have type 2 diabetes with inadequate glycemic control (hemoglobin A1c between 7% and 10.5%) and uncontrolled hypertension (seated systolic blood pressure of 140 to 165 mm Hg and seated diastolic blood pressure 85 to 105 mm Hg)
- Mean 24-hour BP>=130/80 mmHg determined by ABPM
- Stable dose of oral antidiabetic agent (OAD) for at least 6 weeks (12 weeks for thiazolidinedione) or a stable daily dose of insulin as monotherapy or in combination with another OAD, for 8 weeks, and a stable dose of an angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker for at least 4 weeks
- C-peptide level ≥0.8 ng/mL
- Body mass index ≤ 45.0 kg/m^2
Key exclusion criteria
- Aspartate aminotransferase or alanine aminotransferase level >3*upper limit of normal (ULN)
- Serum total bilirubin level >1.5*ULN
- Serum creatinine ≥2.0 mg/dL unless subject was on metformin, where exclusionary limits were serum creatinine ≥1.50 mg/dL for men and ≥1.40 mg/dL for women
- Estimated creatinine clearance of <60 mL/min
- Hemoglobin ≤10.0 g/dL for men and ≤9.0 g/dL for women
- Creatine kinase >3*ULN
- Positive for hepatitis B surface antigen
- Positive for antihepatitis C virus antibody
- Abnormal free T4 value
- History of diabetes insipidus
- Symptoms of poorly controlled diabetes that would preclude participation in this trial, including but not limited to, marked polyuria and polydipsia with greater than 10% weight loss during the 3 months prior to enrollment.
- History of diabetic ketoacidosis or hyperosmolar nonketotic coma
- History of malignant and accelerated hypertension
- Known or suspected secondary hypertension
Any of the following within 6 months of enrollment visit:
- Myocardial infarction
- Cardiac surgery or revascularization (coronary artery bypass surgery /percutaneous transluminal coronary angioplasty)
- Unstable angina
- Unstable congestive heart disease or New York Heart Association Class III or IV
- Transient ischemic attack or significant cerebrovascular disease
- Unstable or previously undiagnosed arrhythmia
Sites / Locations
- University Of Alabama At Birmingham
- Horizon Research Group, Inc.
- Iicr, Inc. (International Institute Of Clinical Research)
- Hope Research Institute
- 43rd Medical Associates
- Central Phoenix Medical Clinic, Llc
- Clinical Research Advantage/Desert Clinical Research
- Visions Clinical Research - Tucson
- Eclipse Clinical Research
- Aureus Research, Inc.
- Preferred Research Partners, Inc.
- Orange County Research Institute
- Cmp Research
- Med Center
- Catalina Research Institute, Llc
- Southland Clinical Research Center, Inc.
- Marin Endocrine Care & Research, Inc.
- Del Rosario Medical Clinic, Inc.
- Time Clinical Research Inc.
- Marina Raikhel, M.D., F.A.A.F.P
- Clinica Medica San Miguel
- American Institute Of Research
- Randall G. Shue, D.O.
- National Research Inst
- Quest Diagnostics West Hills
- Diabetes Medical Center Of California
- Valley Clinical Trials
- Lucita M. Cruz,Md.,Inc.
- Sds Clinical Trials
- Integrated Research Group, Inc.
- Quality Control Research, Inc
- Crest Clinical Trials, Inc.
- Orrin M. Troum, Md And Medical Associates
- Orange County Research Center
- University Clinical Investigators, Inc.
- Infosphere Clinical Research, Inc.
- Aurora Family Medicine, P.C.
- Horizons Clinical Research Center, Llc
- Chase Medical Research, Llc
- Zasa Clinical Research
- Bradenton Research Center, Inc.
- Meridien Research
- Family Care Associates Of Nw Fl
- Innovative Research Of West Florida, Inc
- Clinical Research Of South Florida
- Avail Clinical Research, Llc
- In Vivo Clinical Research
- Palm Springs Research Institute
- The Community Research Of South Florida
- Newphase Clinical Trials, Inc.
- Ocean Blue Medical Research Center, Inc.
- San Marcus Research Clinic, Inc.
- Flcri Global Research, Llc
- International Research Associates, Llc
- Clinical Research Of Miami, Inc.
- Apf Research, Llc
- Community Research Foundation, Inc.
- Medical Research Marseilles
- Baptist Diabetes Associates, Pa
- Suncoast Clinical Research, Inc.
- Compass Research, Llc
- Florida Institute For Clinical Research, Llc
- South Miami Clinical Research, Llc
- Meridien Research
- Meridien Research
- Perimeter Institute For Clinical Research
- Bainbridge Medical Associates
- River Birch Research Alliance, Llc
- In-Quest Medical Research, Llc
- Middle Georgia Clinical Research Center, Llc
- Endocrine Research Solutions, Inc.
- Cedar Crosse Research Center
- James R. Herron, Md, Ltd
- So. Illinois Clin Res Ctr @ Div Of Kevin L Pritchett Md, Pc
- Springfield Diabetes And Endocrine Center
- American Health Network Of Indiana Llc
- Investigators Research Group, Llc
- American Health Network Of In Llc
- Laporte County Institute For Clinical Research, Inc.
- American Health Network Of In Llc
- Medical Development Centers, Llc
- Crescent City Clinical Research Center
- Acadia Clinical Research, Llc
- Alternative Primary Care
- Neurocare, Inc.
- Genesis Clinical Research, Llc
- Hci-Metromedic Walk-In Medical Office
- Atlantic Clinical Trials, Llc
- Providence Park Clinical Research
- The Center For Clinical Trials
- Phillips Medical Services, Pllc
- Jackson Clinic
- Jefferson City Medical Group
- St. Louis Center For Clinical Research
- Kcumb Dybedal Clinical Research Center
- Clin Research Advantage, Inc. James Meli, Do Family Pracice
- Office Of Ted Thorp, Md
- Independent Clinical Researchers@ Wolfson Medical Center
- Clinical Research Advantage, Inc.
- Palm Medical Research Center
- Joslin Diabetes Center Affiliate Of Snhmc
- Central Jersey Medical Research Center
- Premier Research
- Medex Healthcare Research, Inc.
- Digiovanna Institute For Medical Education & Research
- Southgate Medical Group
- Barat Research Group, Inc.
- Pharmquest
- Burke Primary Care
- Pmg Research Of Wilmington Llc
- Lillestol Research
- Community Health Care, Inc.
- Community Research
- Cleveland Sleep Research Center
- Clinical Research Source, Inc
- Integris Family Care Central
- Sooner Clinical Research
- Integris Family Care Yukon
- Willamette Valley Clinical Studies
- Fanno Creek Clinic
- Southeastern Pa Medical Institute
- Abington Memorial Hos/Feasterville Family Health Care Center
- The Clinical Trial Center, Llc
- Arcuri Clinical Research Llc
- Philadelphia Health Associates - Adult Medicine
- Banksville Medical Pc
- Research Across America
- Pish Medical Associates
- Greater Providence Clinical Research, Llc
- Southeastern Research Associates, Inc.
- Southeastern Research Associates, Inc.
- Hillcrest Clinical Reseach, Llc
- Palmetto Clinical Research
- Chattanooga Research & Medicine, Pllc
- Complete Family Care Of Knoxville, Pllc
- Premier Internal Medicine
- Arlington Family Research Center, Inc.
- Krk Medical Research
- Research Institute Of Dallas
- Internal Medicine Clinical Research
- Renaissance Clinical Research And Hypertension Pllc
- Sergio F. Rovner, M.D.
- Mercury Clinical Research
- Southwest Clinical Trials
- Excel Clinical Research, Llc
- Lone Star Clinical Research
- Hill Country Medical Associates
- North Hills Medical Research, Inc.
- Med-Olam Clinical Research
- Lisa E. Medwedeff, Md, Pa
- Sun Research Institute
- Abbott Clinical Research Group, Inc.
- Covenant Clinical Research, Pa
- Breco Research, Ltd
- Pioneer Research Solutions, Inc.
- Exodus Healthcare Network
- Wasatch Endocrinology And Diabetes Specialists
- Wasatch Clinical Research
- Millennium Clinical Trials Llc
- Burke Internal Medicine And Research
- Manassas Clinical Research Center
- Hampton Roads Center For Clinical Research, Inc.
- Tidewater Integrated Medical Research
- Sound Medical Research
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
- Local Institution
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Placebo Comparator
Experimental
Experimental
Dapagliflozin, 10 mg
Placebo-matching dapagliflozin
Dapagliflozin, 2. 5 mg
Dapagliflozin, 5 mg
Oral tablets administered as 10 mg once daily for up to 12 weeks
Oral tablets administered once daily in the morning
Oral tablets administered as 2.5 mg once daily for up to 12 weeks (Arm discontinued as of Protocol Amendment 8)
Oral tablets administered as 5 mg once daily for up to 12 weeks (Arm discontinued as of Protocol Amendment 8)